Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

153 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Relation between Plasma Trough Concentration of Pazopanib and Progression-Free Survival in Metastatic Soft Tissue Sarcoma Patients.
Minot-This MS, Boudou-Rouquette P, Jouinot A, de Percin S, Balakirouchenane D, Khoudour N, Tlemsani C, Chauvin J, Thomas-Schoemann A, Goldwasser F, Blanchet B, Alexandre J. Minot-This MS, et al. Among authors: blanchet b. Pharmaceutics. 2022 Jun 9;14(6):1224. doi: 10.3390/pharmaceutics14061224. Pharmaceutics. 2022. PMID: 35745797 Free PMC article.
Treatment of bevacizumab-induced hypertension by amlodipine.
Mir O, Coriat R, Ropert S, Cabanes L, Blanchet B, Camps S, Billemont B, Knebelmann B, Goldwasser F. Mir O, et al. Among authors: blanchet b. Invest New Drugs. 2012 Apr;30(2):702-7. doi: 10.1007/s10637-010-9549-5. Epub 2010 Sep 29. Invest New Drugs. 2012. PMID: 20878444
More on aprepitant for erlotinib-induced pruritus.
Mir O, Blanchet B, Goldwasser F. Mir O, et al. Among authors: blanchet b. N Engl J Med. 2011 Feb 3;364(5):487. doi: 10.1056/NEJMc1013027. N Engl J Med. 2011. PMID: 21288111 No abstract available.
Functional and clinical evidence of the influence of sorafenib binding to albumin on sorafenib disposition in adult cancer patients.
Tod M, Mir O, Bancelin N, Coriat R, Thomas-Schoemann A, Taieb F, Boudou-Rouquette P, Ropert S, Michels J, Abbas H, Durand JP, Dauphin A, Vidal M, Goldwasser F, Blanchet B. Tod M, et al. Among authors: blanchet b. Pharm Res. 2011 Dec;28(12):3199-207. doi: 10.1007/s11095-011-0499-1. Epub 2011 Jun 21. Pharm Res. 2011. PMID: 21691893
A simple HPLC-UV method for the simultaneous quantification of gefitinib and erlotinib in human plasma.
Faivre L, Gomo C, Mir O, Taieb F, Schoemann-Thomas A, Ropert S, Vidal M, Dusser D, Dauphin A, Goldwasser F, Blanchet B. Faivre L, et al. Among authors: blanchet b. J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Aug 1;879(23):2345-50. doi: 10.1016/j.jchromb.2011.06.026. Epub 2011 Jun 22. J Chromatogr B Analyt Technol Biomed Life Sci. 2011. PMID: 21737360
Drug-induced effects on erlotinib metabolism.
Mir O, Blanchet B, Goldwasser F. Mir O, et al. Among authors: blanchet b. N Engl J Med. 2011 Jul 28;365(4):379-80. doi: 10.1056/NEJMc1105083. N Engl J Med. 2011. PMID: 21793762 No abstract available.
Saturable absorption of sorafenib in patients with solid tumors: a population model.
Hornecker M, Blanchet B, Billemont B, Sassi H, Ropert S, Taieb F, Mir O, Abbas H, Harcouet L, Coriat R, Dauphin A, Goldwasser F, Tod M. Hornecker M, et al. Among authors: blanchet b. Invest New Drugs. 2012 Oct;30(5):1991-2000. doi: 10.1007/s10637-011-9760-z. Epub 2011 Oct 18. Invest New Drugs. 2012. PMID: 22006162 Clinical Trial.
153 results